News Conference News ESC 2024 Endometriosis and CV Risk: Link Needs Further Attention and Research Yael L. Maxwell September 12, 2024
News Conference News ESC 2024 Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA Caitlin E. Cox September 04, 2024
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Conference News ESC 2021 STEP Trial Supports Lower BP Goal in Older Patients With Hypertension Todd Neale August 30, 2021
News Conference News ESC 2020 Got Mail? Letter-Based Intervention Doesn’t Boost OAC Initiation for A-fib Todd Neale September 03, 2020
News Conference News ESC 2019 Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4 Michael O'Riordan September 02, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Conference News ESC 2016 New ESC A-fib Guidelines Call for Integrated Care for All Patients Todd Neale August 27, 2016
News Conference News ESC 2015 Failed Trial PRomPTs Questions About Role of Peri-Infarct Pacing for Remodeling of Large MIs L.A. McKeown August 30, 2015
News Conference News ESC 2014 FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients Yael L. Maxwell September 02, 2014
News Conference News ESC 2013 ESC Congress 2013: Mix of Trials with Potential to Reshape Practice September 09, 2013
News Conference News ESC 2013 PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk Yael L. Maxwell September 04, 2013